Maresca Fabio, D'Ascoli Greta Luana, Ziviello Francesca, Petrillo Gianluca, Di Palma Vito, Russo Angelo, Grieco Alessandra, Cirillo Plinio
Dipartimento di Medicina Clinica, Scienze Cardiovascolari ed Immunologiche, Università degli Studi di Napoli "Federico II", Italy.
Monaldi Arch Chest Dis. 2011 Mar;76(1):13-21. doi: 10.4081/monaldi.2011.201.
Obesity, the most common nutritional disorder in Western countries, is usually associated to cardiovascular diseases. However, the precise molecular pathways underlying this close association remain poorly understood. Nowadays, the adipose tissue is considered as an endocrine organ able to produce substances called adipo(cyto)kines that have different effects on lipid metabolism, closely involved in metabolic syndrome, and cardiovascular risk. The increased cardiovascular risk can be related also to peculiar dysfunction in the endocrine activity of adipose tissue observed in obesity responsible of vascular impairment (including endothelial dysfunction), prothrombotic tendency, and low-grade chronic inflammation. The present review aims at providing an up-dated overview on the adipocyte-derived molecules potentially involved in cardiovascular pathophysiology.
肥胖是西方国家最常见的营养失调症,通常与心血管疾病相关。然而,这种紧密关联背后的确切分子途径仍知之甚少。如今,脂肪组织被认为是一个内分泌器官,能够产生称为脂肪(细胞)因子的物质,这些物质对脂质代谢有不同影响,与代谢综合征和心血管风险密切相关。心血管风险增加也可能与肥胖时观察到的脂肪组织内分泌活动的特殊功能障碍有关,这种功能障碍会导致血管损伤(包括内皮功能障碍)、血栓形成倾向和低度慢性炎症。本综述旨在提供关于可能参与心血管病理生理学的脂肪细胞衍生分子的最新概述。